Atlas Trials

Esmolol Infusion for Patients With Septic Shock and Persistent Tachycardia

Clinical trial NCT02841241 · COMPLETED

Trial details

NCT number
NCT02841241
Sponsor
Intermountain Health Care, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Septic Shock
Start date
2016-04-01
Primary completion
2017-03-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.